复星医药自研创新药枸橼酸伏维西利胶囊复妥宁®获批上市

复星
03 Jun

5月29日,复星医药宣布,控股子公司锦州奥鸿药业有限责任公司(奥鸿药业)自主研发的枸橼酸伏维西利胶囊(商品名:复妥宁®,项目代号:FCN-437c;以下简称“该新药”)于近日获国家药品监督管理局(以下简称“国家药监局”)批准上市,本次获批适应症为联合氟维司群用于既往接受内分泌治疗后出现疾病进展的激素受体(HR)阳性、人表皮生长因子2 (HER2)阴性的复发或转移性成年乳腺癌患者。该新药为复星医药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10